For years, one of the biggest barriers I hear from patients about GLP-1 weight loss medication isn’t the cost, the side effects, or the eligibility criteria. It’s the needle. Now,
The NHS is under pressure — but your health isn’t waiting If you have tried to book a routine health review through your NHS GP recently, you will know the
GLP-1 medications like Mounjaro (tirzepatide) and Wegovy (semaglutide) have transformed obesity medicine. The results can be remarkable. But for many patients across the UK, the question isn’t just how much
In a previous post, we explored the class of medications known as GLP-1 receptor agonists and their growing role in medically supervised weight management. Since that post, a number of
When you notice a skin lesion that is bothering you — whether that is a mole that has changed, a cyst that keeps returning, a lipoma that has grown, or
If you are living with persistent joint pain, stiffness, or inflammation in Belfast or across Northern Ireland, you may have been told that a joint injection could help. But what
Over the past few years, there has been significant attention — in medical journals, in the media, and in everyday conversation — around a new class of treatments for obesity
